Asuragen Publishes Details about miRNA Pancreatic Cancer Test, Stresses Importance of Validation Process

In a recent paper, Asuragen researchers described the miRNAs measured by the test and discussed its accuracy in distinguishing pancreatic cancer from chronic pancreatitis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories